Wrays is not like any other intellectual property firm. We are a patent and trade marks attorney firm, a law firm, and a corporate advisory service provider, delivering specialist, end to-end IP solutions to our clients across Australia and internationally.
Wrays is part of the Rouse group, one of the very few IP Service firms providing a truly global service offering. The Rouse Group includes: Rouse, Wrays, aera, Konsert and Arnold & Siedsma.
Find out more at wrays.com.au.
Why work with us
Why Choose Wrays?
Experience that matters: Wrays’ success is based on creating and maintaining successful professional relationships with our clients. We have a strong track record acting for global pharmaceutical and biotechnology companies. These companies have chosen Wrays because of their extensive commercial experience and expertise, flexible approach and the spectrum of their service offering.
Prosecution Expertise: Wrays brings together a team of highly experienced patent prosecutors that are drawn from industry and IP Australia (the Patent Office) that have a wide range of pharmaceutical, chemistry, biochemistry and pharmacological experience. Our prosecutors in the life science space are also at the forefront of the prosecution field with the team having prosecuted many of the leading cases in the life sciences.
Integrated Patent and Dispute Resolution Expertise: Wrays’ integrated litigation and dispute resolution expertise is one of the key features that differentiates Wrays from many other IP firms within Australia. Having a litigation team which is woven into the architecture of the firm provides continual quality control on the information provided to clients. The team at Wrays take accountability for their advice because we know that they may be responsible for enforcing it.
FDA Track Record: Wrays is immensely proud of our track record and the role we have played in securing FDA approval for their clients. In total, Australian University research organisations have developed 17 drugs that have successfully received approval from the United States Food and Drug Administration (FDA). Of these 17, seven were patented by Wrays. This is an incredible achievement and
cannot be matched by any other Australian IP firm.
Quick Response and Quick Turnaround: Our team pride themselves on their quick response and turnaround without compromising on quality. Our dedication to
providing timely responses has become a hallmark of the Wrays service, and we are continually focused on maintaining this standard of excellence.
